AFP is a crucial regulator of cell proliferation in liver cancer, its expression in the serum of hepatoma-bearing mice was also higher than in the control group, but the presentation was not reduced after CPhGs treatment lasted for 21 days. Here, AFP is linked to hepatocellular carcinoma.